APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Nausea and Vomiting Healthcare Device

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anti-Nausea and Vomiting Healthcare Device Market Analysis and Forecast 2026-2032

30 December 2025191 pages

Choose your research edition.

Industry ResearchAnti-Nausea and Vomiting Healthcare Device Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Nausea and Vomiting Healthcare Device Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Anti-Nausea and Vomiting Healthcare Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Nausea and Vomiting Healthcare Device Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Nausea and Vomiting Healthcare Device Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Anti-Nausea and Vomiting Healthcare Device market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anti-Nausea and Vomiting Healthcare Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti-Nausea and Vomiting Healthcare Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti-Nausea and Vomiting Healthcare Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti-Nausea and Vomiting Healthcare Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Anti-Nausea and Vomiting Healthcare Device include Blisslets, Dramamine(Prestige Consumer Healthcare), EmeTerm (WAT Medical), GRAVOL, MotionCure (Sidis Labs), NoMo, Psi Bands, Quease EASE (Soothing Scents) and Reliefband, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anti-Nausea and Vomiting Healthcare Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-Nausea and Vomiting Healthcare Device, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-Nausea and Vomiting Healthcare Device, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-Nausea and Vomiting Healthcare Device sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-Nausea and Vomiting Healthcare Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anti-Nausea and Vomiting Healthcare Device sales, projected growth trends, production technology, application and end-user industry.

Anti-Nausea and Vomiting Healthcare Device Segment by Company

Blisslets

Dramamine(Prestige Consumer Healthcare)

EmeTerm (WAT Medical)

GRAVOL

MotionCure (Sidis Labs)

NoMo

Psi Bands

Quease EASE (Soothing Scents)

Reliefband

Sea-Bands

Toulifly

Walgreens

Anti-Nausea and Vomiting Healthcare Device Segment by Type

Inhaler

Wrist Band

Food

Others

Anti-Nausea and Vomiting Healthcare Device Segment by Application

For Children

For Pregnant

For other people with motion sickness

Anti-Nausea and Vomiting Healthcare Device Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Nausea and Vomiting Healthcare Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Nausea and Vomiting Healthcare Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Nausea and Vomiting Healthcare Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Anti-Nausea and Vomiting Healthcare Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Anti-Nausea and Vomiting Healthcare Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Nausea and Vomiting Healthcare Device sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Inhaler Major Manufacturers Table 3. Wrist Band Major Manufacturers Table 4. Food Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. For Children Major Manufacturers Table 8. For Pregnant Major Manufacturers Table 9. For other people with motion sickness Major Manufacturers Table 10. Anti-Nausea and Vomiting Healthcare Device Industry Trends Table 11. Anti-Nausea and Vomiting Healthcare Device Industry Drivers Table 12. Anti-Nausea and Vomiting Healthcare Device Industry Opportunities and Challenges Table 13. Anti-Nausea and Vomiting Healthcare Device Industry Restraints Table 14. Global Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Region (2021-2026) Table 18. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Region (2027-2032) Table 19. Global Anti-Nausea and Vomiting Healthcare Device Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2021-2026) & (K Units) Table 21. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2027-2032) & (K Units) Table 22. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Region (2021-2026) Table 23. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Region (2027-2032) Table 24. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Anti-Nausea and Vomiting Healthcare Device Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Manufacturers (2021-2026) Table 28. Global Anti-Nausea and Vomiting Healthcare Device Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Anti-Nausea and Vomiting Healthcare Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Anti-Nausea and Vomiting Healthcare Device Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Anti-Nausea and Vomiting Healthcare Device Manufacturers, Product Type & Application Table 32. Global Anti-Nausea and Vomiting Healthcare Device Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Anti-Nausea and Vomiting Healthcare Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2021-2026) Table 39. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2027-2032) Table 40. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 42. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2027-2032) & (K Units) Table 43. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2021-2026) Table 44. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2027-2032) Table 45. Global Anti-Nausea and Vomiting Healthcare Device Price by Type (2021-2026) & (US$/Unit) Table 46. Global Anti-Nausea and Vomiting Healthcare Device Price by Type (2027-2032) & (US$/Unit) Table 47. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application (2021-2026) Table 51. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application (2027-2032) Table 52. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 54. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2027-2032) & (K Units) Table 55. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2021-2026) Table 56. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2027-2032) Table 57. Global Anti-Nausea and Vomiting Healthcare Device Price by Application (2021-2026) & (US$/Unit) Table 58. Global Anti-Nausea and Vomiting Healthcare Device Price by Application (2027-2032) & (US$/Unit) Table 59. Blisslets Company Information Table 60. Blisslets Business Overview Table 61. Blisslets Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Blisslets Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 63. Blisslets Recent Development Table 64. Dramamine(Prestige Consumer Healthcare) Company Information Table 65. Dramamine(Prestige Consumer Healthcare) Business Overview Table 66. Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 68. Dramamine(Prestige Consumer Healthcare) Recent Development Table 69. EmeTerm (WAT Medical) Company Information Table 70. EmeTerm (WAT Medical) Business Overview Table 71. EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 73. EmeTerm (WAT Medical) Recent Development Table 74. GRAVOL Company Information Table 75. GRAVOL Business Overview Table 76. GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 78. GRAVOL Recent Development Table 79. MotionCure (Sidis Labs) Company Information Table 80. MotionCure (Sidis Labs) Business Overview Table 81. MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 83. MotionCure (Sidis Labs) Recent Development Table 84. NoMo Company Information Table 85. NoMo Business Overview Table 86. NoMo Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. NoMo Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 88. NoMo Recent Development Table 89. Psi Bands Company Information Table 90. Psi Bands Business Overview Table 91. Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 93. Psi Bands Recent Development Table 94. Quease EASE (Soothing Scents) Company Information Table 95. Quease EASE (Soothing Scents) Business Overview Table 96. Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 98. Quease EASE (Soothing Scents) Recent Development Table 99. Reliefband Company Information Table 100. Reliefband Business Overview Table 101. Reliefband Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Reliefband Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 103. Reliefband Recent Development Table 104. Sea-Bands Company Information Table 105. Sea-Bands Business Overview Table 106. Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 108. Sea-Bands Recent Development Table 109. Toulifly Company Information Table 110. Toulifly Business Overview Table 111. Toulifly Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Toulifly Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 113. Toulifly Recent Development Table 114. Walgreens Company Information Table 115. Walgreens Business Overview Table 116. Walgreens Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Walgreens Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 118. Walgreens Recent Development Table 119. North America Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2026) & (US$ Million) Table 120. North America Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2027-2032) & (US$ Million) Table 121. North America Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 122. North America Anti-Nausea and Vomiting Healthcare Device Sales by Type (2027-2032) & (K Units) Table 123. North America Anti-Nausea and Vomiting Healthcare Device Sales Price by Type (2021-2026) & (US$/Unit) Table 124. North America Anti-Nausea and Vomiting Healthcare Device Sales Price by Type (2027-2032) & (US$/Unit) Table 125. North America Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2026) & (US$ Million) Table 126. North America Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2027-2032) & (US$ Million) Table 127. North America Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 128. North America Anti-Nausea and Vomiting Healthcare Device Sales by Application (2027-2032) & (K Units) Table 129. North America Anti-Nausea and Vomiting Healthcare Device Sales Price by Application (2021-2026) & (US$/Unit) Table 130. North America Anti-Nausea and Vomiting Healthcare Device Sales Price by Application (2027-2032) & (US$/Unit) Table 131. North America Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. North America Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. North America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 135. North America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 136. North America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2027-2032) & (K Units) Table 137. North America Anti-Nausea and Vomiting Healthcare Device Sales Price by Country (2021-2026) & (US$/Unit) Table 138. North America Anti-Nausea and Vomiting Healthcare Device Sales Price by Country (2027-2032) & (US$/Unit) Table 139. United States Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 140. Canada Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 141. Europe Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2026) & (US$ Million) Table 142. Europe Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2027-2032) & (US$ Million) Table 143. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 144. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Type (2027-2032) & (K Units) Table 145. Europe Anti-Nausea and Vomiting Healthcare Device Sales Price by Type (2021-2026) & (US$/Unit) Table 146. Europe Anti-Nausea and Vomiting Healthcare Device Sales Price by Type (2027-2032) & (US$/Unit) Table 147. Europe Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2026) & (US$ Million) Table 148. Europe Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2027-2032) & (US$ Million) Table 149. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 150. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Application (2027-2032) & (K Units) Table 151. Europe Anti-Nausea and Vomiting Healthcare Device Sales Price by Application (2021-2026) & (US$/Unit) Table 152. Europe Anti-Nausea and Vomiting Healthcare Device Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Europe Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Europe Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 157. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 158. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2027-2032) & (K Units) Table 159. Europe Anti-Nausea and Vomiting Healthcare Device Sales Price by Country (2021-2026) & (US$/Unit) Table 160. Europe Anti-Nausea and Vomiting Healthcare Device Sales Price by Country (2027-2032) & (US$/Unit) Table 161. Germany Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 162. France Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 163. U.K. Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 164. Italy Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 165. Netherlands Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 166. China Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2026) & (US$ Million) Table 167. China Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2027-2032) & (US$ Million) Table 168. China Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 169. China Anti-Nausea and Vomiting Healthcare Device Sales by Type (2027-2032) & (K Units) Table 170. China Anti-Nausea and Vomiting Healthcare Device Sales Price by Type (2021-2026) & (US$/Unit) Table 171. China Anti-Nausea and Vomiting Healthcare Device Sales Price by Type (2027-2032) & (US$/Unit) Table 172. China Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2026) & (US$ Million) Table 173. China Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2027-2032) & (US$ Million) Table 174. China Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 175. China Anti-Nausea and Vomiting Healthcare Device Sales by Application (2027-2032) & (K Units) Table 176. China Anti-Nausea and Vomiting Healthcare Device Sales Price by Application (2021-2026) & (US$/Unit) Table 177. China Anti-Nausea and Vomiting Healthcare Device Sales Price by Application (2027-2032) & (US$/Unit) Table 178. Asia Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 181. Asia Anti-Nausea and Vomiting Healthcare Device Sales by Type (2027-2032) & (K Units) Table 182. Asia Anti-Nausea and Vomiting Healthcare Device Sales Price by Type (2021-2026) & (US$/Unit) Table 183. Asia Anti-Nausea and Vomiting Healthcare Device Sales Price by Type (2027-2032) & (US$/Unit) Table 184. Asia Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 187. Asia Anti-Nausea and Vomiting Healthcare Device Sales by Application (2027-2032) & (K Units) Table 188. Asia Anti-Nausea and Vomiting Healthcare Device Sales Price by Application (2021-2026) & (US$/Unit) Table 189. Asia Anti-Nausea and Vomiting Healthcare Device Sales Price by Application (2027-2032) & (US$/Unit) Table 190. Asia Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 194. Asia Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 195. Asia Anti-Nausea and Vomiting Healthcare Device Sales by Country (2027-2032) & (K Units) Table 196. Asia Anti-Nausea and Vomiting Healthcare Device Sales Price by Country (2021-2026) & (US$/Unit) Table 197. Asia Anti-Nausea and Vomiting Healthcare Device Sales Price by Country (2027-2032) & (US$/Unit) Table 198. Japan Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 199. South Korea Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 200. India Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 201. Australia Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 202. China Taiwan Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 204. SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 207. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales by Type (2027-2032) & (K Units) Table 208. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales Price by Type (2021-2026) & (US$/Unit) Table 209. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales Price by Type (2027-2032) & (US$/Unit) Table 210. SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 213. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales by Application (2027-2032) & (K Units) Table 214. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales Price by Application (2021-2026) & (US$/Unit) Table 215. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales Price by Application (2027-2032) & (US$/Unit) Table 216. SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 220. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 221. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales by Country (2027-2032) & (K Units) Table 222. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales Price by Country (2021-2026) & (US$/Unit) Table 223. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales Price by Country (2027-2032) & (US$/Unit) Table 224. Brazil Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 225. Argentina Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 226. Chile Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 227. Colombia Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 228. Peru Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 230. Israel Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 231. UAE Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 232. Turkey Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 233. Iran Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 234. Egypt Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Anti-Nausea and Vomiting Healthcare Device Distributors List Table 238. Anti-Nausea and Vomiting Healthcare Device Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Anti-Nausea and Vomiting Healthcare Device Image Figure 2. Global Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Nausea and Vomiting Healthcare Device Market Size Share 2021 VS 2025 VS 2032 Figure 4. Inhaler Image Figure 5. Wrist Band Image Figure 6. Food Image Figure 7. Others Image Figure 8. Global Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Anti-Nausea and Vomiting Healthcare Device Market Size Share 2021 VS 2025 VS 2032 Figure 10. For Children Image Figure 11. For Pregnant Image Figure 12. For other people with motion sickness Image Figure 13. Global Anti-Nausea and Vomiting Healthcare Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Figure 15. Global Anti-Nausea and Vomiting Healthcare Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Region (2021-2032) Figure 18. Global Anti-Nausea and Vomiting Healthcare Device Sales (2021-2032) & (K Units) Figure 19. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Anti-Nausea and Vomiting Healthcare Device Sales YoY (2021-2032) & (K Units) Figure 22. Europe Anti-Nausea and Vomiting Healthcare Device Sales YoY (2021-2032) & (K Units) Figure 23. China Anti-Nausea and Vomiting Healthcare Device Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Anti-Nausea and Vomiting Healthcare Device Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales YoY (2021-2032) & (K Units) Figure 26. Global Anti-Nausea and Vomiting Healthcare Device Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Anti-Nausea and Vomiting Healthcare Device Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2021-2032) Figure 32. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2021-2032) Figure 35. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application (2021-2032) Figure 38. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2021-2032) Figure 41. North America Anti-Nausea and Vomiting Healthcare Device Revenue Share by Type (2021-2032) Figure 42. North America Anti-Nausea and Vomiting Healthcare Device Sales Share by Type (2021-2032) Figure 43. North America Anti-Nausea and Vomiting Healthcare Device Revenue Share by Application (2021-2032) Figure 44. North America Anti-Nausea and Vomiting Healthcare Device Sales Share by Application (2021-2032) Figure 45. North America Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country (2021-2032) Figure 46. North America Anti-Nausea and Vomiting Healthcare Device Sales Share by Country (2021-2032) Figure 47. Europe Anti-Nausea and Vomiting Healthcare Device Revenue Share by Type (2021-2032) Figure 48. Europe Anti-Nausea and Vomiting Healthcare Device Sales Share by Type (2021-2032) Figure 49. Europe Anti-Nausea and Vomiting Healthcare Device Revenue Share by Application (2021-2032) Figure 50. Europe Anti-Nausea and Vomiting Healthcare Device Sales Share by Application (2021-2032) Figure 51. Europe Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country (2021-2032) Figure 52. Europe Anti-Nausea and Vomiting Healthcare Device Sales Share by Country (2021-2032) Figure 53. China Anti-Nausea and Vomiting Healthcare Device Revenue Share by Type (2021-2032) Figure 54. China Anti-Nausea and Vomiting Healthcare Device Sales Share by Type (2021-2032) Figure 55. China Anti-Nausea and Vomiting Healthcare Device Revenue Share by Application (2021-2032) Figure 56. China Anti-Nausea and Vomiting Healthcare Device Sales Share by Application (2021-2032) Figure 57. Asia Anti-Nausea and Vomiting Healthcare Device Revenue Share by Type (2021-2032) Figure 58. Asia Anti-Nausea and Vomiting Healthcare Device Sales Share by Type (2021-2032) Figure 59. Asia Anti-Nausea and Vomiting Healthcare Device Revenue Share by Application (2021-2032) Figure 60. Asia Anti-Nausea and Vomiting Healthcare Device Sales Share by Application (2021-2032) Figure 61. Asia Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country (2021-2032) Figure 62. Asia Anti-Nausea and Vomiting Healthcare Device Sales Share by Country (2021-2032) Figure 63. SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue Share by Type (2021-2032) Figure 64. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales Share by Type (2021-2032) Figure 65. SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue Share by Application (2021-2032) Figure 66. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales Share by Application (2021-2032) Figure 67. SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country (2021-2032) Figure 68. SAMEA Anti-Nausea and Vomiting Healthcare Device Sales Share by Country (2021-2032) Figure 69. Anti-Nausea and Vomiting Healthcare Device Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Anti-Nausea and Vomiting Healthcare Device Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Inhaler
  • Wrist Band
  • Food
  • Others
Applications
  • For Children
  • For Pregnant
  • For other people with motion sickness
Companies covered
  • Blisslets
  • Dramamine(Prestige Consumer Healthcare)
  • EmeTerm (WAT Medical)
  • GRAVOL
  • MotionCure (Sidis Labs)
  • NoMo
  • Psi Bands
  • Quease EASE (Soothing Scents)
  • Reliefband
  • Sea-Bands
  • Toulifly
  • Walgreens

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-Nausea and Vomiting Healthcare Device Market by Type
  3. 1.2.1 Global Anti-Nausea and Vomiting Healthcare Device Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Inhaler
  5. 1.2.3 Wrist Band
  6. 1.2.4 Food
  7. 1.2.5 Others
  8. 1.3 Anti-Nausea and Vomiting Healthcare Device Market by Application
  9. 1.3.1 Global Anti-Nausea and Vomiting Healthcare Device Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 For Children
  11. 1.3.3 For Pregnant
  12. 1.3.4 For other people with motion sickness
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Anti-Nausea and Vomiting Healthcare Device Market Dynamics
  1. 2.1 Anti-Nausea and Vomiting Healthcare Device Industry Trends
  2. 2.2 Anti-Nausea and Vomiting Healthcare Device Industry Drivers
  3. 2.3 Anti-Nausea and Vomiting Healthcare Device Industry Opportunities and Challenges
  4. 2.4 Anti-Nausea and Vomiting Healthcare Device Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region
  3. 3.2.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region (2021-2026)
  5. 3.2.3 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region (2027-2032)
  6. 3.2.4 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region
  9. 3.4.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2021-2026)
  11. 3.4.3 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2027-2032)
  12. 3.4.4 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Manufacturers
  2. 4.1.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Anti-Nausea and Vomiting Healthcare Device Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Manufacturers
  6. 4.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Anti-Nausea and Vomiting Healthcare Device Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Anti-Nausea and Vomiting Healthcare Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Anti-Nausea and Vomiting Healthcare Device Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Anti-Nausea and Vomiting Healthcare Device Manufacturers, Product Type & Application
  13. 4.7 Global Anti-Nausea and Vomiting Healthcare Device Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Anti-Nausea and Vomiting Healthcare Device Market CR5 and HHI
  16. 4.8.2 2025 Anti-Nausea and Vomiting Healthcare Device Tier 1, Tier 2, and Tier 3
5 Anti-Nausea and Vomiting Healthcare Device Market by Type
  1. 5.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type
  2. 5.1.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Type
  6. 5.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2021-2032)
  9. 5.3 Global Anti-Nausea and Vomiting Healthcare Device Price by Type
6 Anti-Nausea and Vomiting Healthcare Device Market by Application
  1. 6.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application
  2. 6.1.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Application
  6. 6.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2021-2032)
  9. 6.3 Global Anti-Nausea and Vomiting Healthcare Device Price by Application
7 Company Profiles
  1. 7.1 Blisslets
  2. 7.1.1 Blisslets Company Information
  3. 7.1.2 Blisslets Business Overview
  4. 7.1.3 Blisslets Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Blisslets Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  6. 7.1.5 Blisslets Recent Developments
  7. 7.2 Dramamine(Prestige Consumer Healthcare)
  8. 7.2.1 Dramamine(Prestige Consumer Healthcare) Company Information
  9. 7.2.2 Dramamine(Prestige Consumer Healthcare) Business Overview
  10. 7.2.3 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  12. 7.2.5 Dramamine(Prestige Consumer Healthcare) Recent Developments
  13. 7.3 EmeTerm (WAT Medical)
  14. 7.3.1 EmeTerm (WAT Medical) Company Information
  15. 7.3.2 EmeTerm (WAT Medical) Business Overview
  16. 7.3.3 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  18. 7.3.5 EmeTerm (WAT Medical) Recent Developments
  19. 7.4 GRAVOL
  20. 7.4.1 GRAVOL Company Information
  21. 7.4.2 GRAVOL Business Overview
  22. 7.4.3 GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  24. 7.4.5 GRAVOL Recent Developments
  25. 7.5 MotionCure (Sidis Labs)
  26. 7.5.1 MotionCure (Sidis Labs) Company Information
  27. 7.5.2 MotionCure (Sidis Labs) Business Overview
  28. 7.5.3 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  30. 7.5.5 MotionCure (Sidis Labs) Recent Developments
  31. 7.6 NoMo
  32. 7.6.1 NoMo Company Information
  33. 7.6.2 NoMo Business Overview
  34. 7.6.3 NoMo Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 NoMo Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  36. 7.6.5 NoMo Recent Developments
  37. 7.7 Psi Bands
  38. 7.7.1 Psi Bands Company Information
  39. 7.7.2 Psi Bands Business Overview
  40. 7.7.3 Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  42. 7.7.5 Psi Bands Recent Developments
  43. 7.8 Quease EASE (Soothing Scents)
  44. 7.8.1 Quease EASE (Soothing Scents) Company Information
  45. 7.8.2 Quease EASE (Soothing Scents) Business Overview
  46. 7.8.3 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  48. 7.8.5 Quease EASE (Soothing Scents) Recent Developments
  49. 7.9 Reliefband
  50. 7.9.1 Reliefband Company Information
  51. 7.9.2 Reliefband Business Overview
  52. 7.9.3 Reliefband Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Reliefband Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  54. 7.9.5 Reliefband Recent Developments
  55. 7.10 Sea-Bands
  56. 7.10.1 Sea-Bands Company Information
  57. 7.10.2 Sea-Bands Business Overview
  58. 7.10.3 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  60. 7.10.5 Sea-Bands Recent Developments
  61. 7.11 Toulifly
  62. 7.11.1 Toulifly Company Information
  63. 7.11.2 Toulifly Business Overview
  64. 7.11.3 Toulifly Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Toulifly Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  66. 7.11.5 Toulifly Recent Developments
  67. 7.12 Walgreens
  68. 7.12.1 Walgreens Company Information
  69. 7.12.2 Walgreens Business Overview
  70. 7.12.3 Walgreens Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Walgreens Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  72. 7.12.5 Walgreens Recent Developments
8 North America
  1. 8.1 North America Anti-Nausea and Vomiting Healthcare Device Market Size by Type
  2. 8.1.1 North America Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2032)
  3. 8.1.2 North America Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2032)
  4. 8.1.3 North America Anti-Nausea and Vomiting Healthcare Device Price by Type (2021-2032)
  5. 8.2 North America Anti-Nausea and Vomiting Healthcare Device Market Size by Application
  6. 8.2.1 North America Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2032)
  7. 8.2.2 North America Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2032)
  8. 8.2.3 North America Anti-Nausea and Vomiting Healthcare Device Price by Application (2021-2032)
  9. 8.3 North America Anti-Nausea and Vomiting Healthcare Device Market Size by Country
  10. 8.3.1 North America Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Anti-Nausea and Vomiting Healthcare Device Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Anti-Nausea and Vomiting Healthcare Device Market Size by Type
  2. 9.1.1 Europe Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2032)
  3. 9.1.2 Europe Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2032)
  4. 9.1.3 Europe Anti-Nausea and Vomiting Healthcare Device Price by Type (2021-2032)
  5. 9.2 Europe Anti-Nausea and Vomiting Healthcare Device Market Size by Application
  6. 9.2.1 Europe Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2032)
  7. 9.2.2 Europe Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2032)
  8. 9.2.3 Europe Anti-Nausea and Vomiting Healthcare Device Price by Application (2021-2032)
  9. 9.3 Europe Anti-Nausea and Vomiting Healthcare Device Market Size by Country
  10. 9.3.1 Europe Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Anti-Nausea and Vomiting Healthcare Device Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Anti-Nausea and Vomiting Healthcare Device Market Size by Type
  2. 10.1.1 China Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2032)
  3. 10.1.2 China Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2032)
  4. 10.1.3 China Anti-Nausea and Vomiting Healthcare Device Price by Type (2021-2032)
  5. 10.2 China Anti-Nausea and Vomiting Healthcare Device Market Size by Application
  6. 10.2.1 China Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2032)
  7. 10.2.2 China Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2032)
  8. 10.2.3 China Anti-Nausea and Vomiting Healthcare Device Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-Nausea and Vomiting Healthcare Device Market Size by Type
  2. 11.1.1 Asia Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2032)
  3. 11.1.2 Asia Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2032)
  4. 11.1.3 Asia Anti-Nausea and Vomiting Healthcare Device Price by Type (2021-2032)
  5. 11.2 Asia Anti-Nausea and Vomiting Healthcare Device Market Size by Application
  6. 11.2.1 Asia Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2032)
  7. 11.2.2 Asia Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2032)
  8. 11.2.3 Asia Anti-Nausea and Vomiting Healthcare Device Price by Application (2021-2032)
  9. 11.3 Asia Anti-Nausea and Vomiting Healthcare Device Market Size by Country
  10. 11.3.1 Asia Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Anti-Nausea and Vomiting Healthcare Device Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-Nausea and Vomiting Healthcare Device Market Size by Type
  2. 12.1.1 SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Anti-Nausea and Vomiting Healthcare Device Price by Type (2021-2032)
  5. 12.2 SAMEA Anti-Nausea and Vomiting Healthcare Device Market Size by Application
  6. 12.2.1 SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Anti-Nausea and Vomiting Healthcare Device Price by Application (2021-2032)
  9. 12.3 SAMEA Anti-Nausea and Vomiting Healthcare Device Market Size by Country
  10. 12.3.1 SAMEA Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Anti-Nausea and Vomiting Healthcare Device Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Anti-Nausea and Vomiting Healthcare Device Value Chain Analysis
  2. 13.1.1 Anti-Nausea and Vomiting Healthcare Device Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Anti-Nausea and Vomiting Healthcare Device Production Mode & Process
  6. 13.2 Anti-Nausea and Vomiting Healthcare Device Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Anti-Nausea and Vomiting Healthcare Device Distributors
  9. 13.2.3 Anti-Nausea and Vomiting Healthcare Device Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst